The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oral Polio Vaccines (OPV) Market Research Report 2024

Global Oral Polio Vaccines (OPV) Market Research Report 2024

Publishing Date : Jul, 2022

License Type :
 

Report Code : 1718349

No of Pages : 93

Ask Your Query

Synopsis

Due to the COVID-19 pandemic, the global Oral Polio Vaccines (OPV) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Oral Polio Vaccines (OPV) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Oral Polio Vaccines (OPV) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Trivalent OPV accounting for % of the Oral Polio Vaccines (OPV) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Public segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Oral Polio Vaccines (OPV) include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In terms of revenue, the global 3 largest players have a % market share of Oral Polio Vaccines (OPV) in 2021.
This report focuses on Oral Polio Vaccines (OPV) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Oral Polio Vaccines (OPV) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Oral Polio Vaccines (OPV) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Trivalent OPV
  • Bivalent OPV

Segment by Application

  • Public
  • Private

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Sanofi
  • GSK
  • Bibcol
  • Serum Institute
  • Tiantan Biological
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals
Index

1 Oral Polio Vaccines (OPV) Market Overview
1.1 Product Overview and Scope of Oral Polio Vaccines (OPV)
1.2 Oral Polio Vaccines (OPV) Segment by Type
1.2.1 Global Oral Polio Vaccines (OPV) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Trivalent OPV
1.2.3 Bivalent OPV
1.3 Oral Polio Vaccines (OPV) Segment by Application
1.3.1 Global Oral Polio Vaccines (OPV) Sales Comparison by Application: (2022-2028)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Polio Vaccines (OPV) Market Size Estimates and Forecasts
1.4.1 Global Oral Polio Vaccines (OPV) Revenue 2017-2028
1.4.2 Global Oral Polio Vaccines (OPV) Sales 2017-2028
1.4.3 Oral Polio Vaccines (OPV) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oral Polio Vaccines (OPV) Market Competition by Manufacturers
2.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Oral Polio Vaccines (OPV) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Oral Polio Vaccines (OPV) Manufacturing Sites, Area Served, Product Type
2.5 Oral Polio Vaccines (OPV) Market Competitive Situation and Trends
2.5.1 Oral Polio Vaccines (OPV) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Polio Vaccines (OPV) Players Market Share by Revenue
2.5.3 Global Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Polio Vaccines (OPV) Retrospective Market Scenario by Region
3.1 Global Oral Polio Vaccines (OPV) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Oral Polio Vaccines (OPV) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.3.1 North America Oral Polio Vaccines (OPV) Sales by Country
3.3.2 North America Oral Polio Vaccines (OPV) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.4.1 Europe Oral Polio Vaccines (OPV) Sales by Country
3.4.2 Europe Oral Polio Vaccines (OPV) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Polio Vaccines (OPV) Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Polio Vaccines (OPV) Sales by Region
3.5.2 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.6.1 Latin America Oral Polio Vaccines (OPV) Sales by Country
3.6.2 Latin America Oral Polio Vaccines (OPV) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Polio Vaccines (OPV) Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country
3.7.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Oral Polio Vaccines (OPV) Historic Market Analysis by Type
4.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2022)
4.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2022)
4.3 Global Oral Polio Vaccines (OPV) Price by Type (2017-2022)
5 Global Oral Polio Vaccines (OPV) Historic Market Analysis by Application
5.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2022)
5.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2022)
5.3 Global Oral Polio Vaccines (OPV) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi Oral Polio Vaccines (OPV) Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GSK Oral Polio Vaccines (OPV) Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bibcol Oral Polio Vaccines (OPV) Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Serum Institute Oral Polio Vaccines (OPV) Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Portfolio
6.6.5 Panacea Biotec Ltd Recent Developments/Updates
6.7 Bio-Med
6.6.1 Bio-Med Corporation Information
6.6.2 Bio-Med Description and Business Overview
6.6.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bio-Med Oral Polio Vaccines (OPV) Product Portfolio
6.7.5 Bio-Med Recent Developments/Updates
6.8 Halfkin Bio-Pharmaceuticals
6.8.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.8.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Portfolio
6.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Oral Polio Vaccines (OPV) Manufacturing Cost Analysis
7.1 Oral Polio Vaccines (OPV) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Polio Vaccines (OPV)
7.4 Oral Polio Vaccines (OPV) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Polio Vaccines (OPV) Distributors List
8.3 Oral Polio Vaccines (OPV) Customers
9 Oral Polio Vaccines (OPV) Market Dynamics
9.1 Oral Polio Vaccines (OPV) Industry Trends
9.2 Oral Polio Vaccines (OPV) Market Drivers
9.3 Oral Polio Vaccines (OPV) Market Challenges
9.4 Oral Polio Vaccines (OPV) Market Restraints
10 Global Market Forecast
10.1 Oral Polio Vaccines (OPV) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Polio Vaccines (OPV) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Oral Polio Vaccines (OPV) by Type (2023-2028)
10.2 Oral Polio Vaccines (OPV) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Polio Vaccines (OPV) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Oral Polio Vaccines (OPV) by Application (2023-2028)
10.3 Oral Polio Vaccines (OPV) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Polio Vaccines (OPV) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Oral Polio Vaccines (OPV) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Oral Polio Vaccines (OPV) Sales Growth Rate Comparison by Type (2022-2028) & (M Doses) & (US$ Million)
Table 2. Global Oral Polio Vaccines (OPV) Sales Growth Rate Comparison by Application (2022-2028) & (M Doses) & (US$ Million)
Table 3. Global Oral Polio Vaccines (OPV) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Oral Polio Vaccines (OPV) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Oral Polio Vaccines (OPV) Sales (M Doses) of Key Manufacturers (2017-2022)
Table 6. Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Oral Polio Vaccines (OPV) Average Price (USD/Doses) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Oral Polio Vaccines (OPV) Manufacturing Sites and Area Served
Table 11. Manufacturers Oral Polio Vaccines (OPV) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oral Polio Vaccines (OPV) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Polio Vaccines (OPV) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oral Polio Vaccines (OPV) Sales by Region (2017-2022) & (M Doses)
Table 16. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2022)
Table 17. Global Oral Polio Vaccines (OPV) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2017-2022)
Table 19. North America Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 20. North America Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2022)
Table 21. North America Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2022)
Table 23. Europe Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 24. Europe Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2022)
Table 25. Europe Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2017-2022) & (M Doses)
Table 28. Asia Pacific Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 32. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2022)
Table 33. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 36. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2022)
Table 39. Global Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 40. Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2022)
Table 41. Global Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Oral Polio Vaccines (OPV) Revenue Share by Type (2017-2022)
Table 43. Global Oral Polio Vaccines (OPV) Price by Type (2017-2022) & (USD/Doses)
Table 44. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Application (2017-2022)
Table 45. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2022)
Table 46. Global Oral Polio Vaccines (OPV) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Oral Polio Vaccines (OPV) Revenue Share by Application (2017-2022)
Table 48. Global Oral Polio Vaccines (OPV) Price by Application (2017-2022) & (USD/Doses)
Table 49. Sanofi Corporation Information
Table 50. Sanofi Description and Business Overview
Table 51. Sanofi Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 52. Sanofi Oral Polio Vaccines (OPV) Product
Table 53. Sanofi Recent Developments/Updates
Table 54. GSK Corporation Information
Table 55. GSK Description and Business Overview
Table 56. GSK Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 57. GSK Oral Polio Vaccines (OPV) Product
Table 58. GSK Recent Developments/Updates
Table 59. Bibcol Corporation Information
Table 60. Bibcol Description and Business Overview
Table 61. Bibcol Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 62. Bibcol Oral Polio Vaccines (OPV) Product
Table 63. Bibcol Recent Developments/Updates
Table 64. Serum Institute Corporation Information
Table 65. Serum Institute Description and Business Overview
Table 66. Serum Institute Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 67. Serum Institute Oral Polio Vaccines (OPV) Product
Table 68. Serum Institute Recent Developments/Updates
Table 69. Tiantan Biological Corporation Information
Table 70. Tiantan Biological Description and Business Overview
Table 71. Tiantan Biological Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 72. Tiantan Biological Oral Polio Vaccines (OPV) Product
Table 73. Tiantan Biological Recent Developments/Updates
Table 74. Panacea Biotec Ltd Corporation Information
Table 75. Panacea Biotec Ltd Description and Business Overview
Table 76. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 77. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product
Table 78. Panacea Biotec Ltd Recent Developments/Updates
Table 79. Bio-Med Corporation Information
Table 80. Bio-Med Description and Business Overview
Table 81. Bio-Med Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 82. Bio-Med Oral Polio Vaccines (OPV) Product
Table 83. Bio-Med Recent Developments/Updates
Table 84. Halfkin Bio-Pharmaceuticals Corporation Information
Table 85. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 86. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 87. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product
Table 88. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 89. Production Base and Market Concentration Rate of Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. Oral Polio Vaccines (OPV) Distributors List
Table 92. Oral Polio Vaccines (OPV) Customers List
Table 93. Oral Polio Vaccines (OPV) Market Trends
Table 94. Oral Polio Vaccines (OPV) Market Drivers
Table 95. Oral Polio Vaccines (OPV) Market Challenges
Table 96. Oral Polio Vaccines (OPV) Market Restraints
Table 97. Global Oral Polio Vaccines (OPV) Sales Forecast by Type (2023-2028) & (M Doses)
Table 98. Global Oral Polio Vaccines (OPV) Sales Market Share Forecast by Type (2023-2028)
Table 99. Global Oral Polio Vaccines (OPV) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Oral Polio Vaccines (OPV) Revenue Market Share Forecast by Type (2023-2028)
Table 101. Global Oral Polio Vaccines (OPV) Sales Forecast by Application (2023-2028) & (M Doses)
Table 102. Global Oral Polio Vaccines (OPV) Sales Market Share Forecast by Application (2023-2028)
Table 103. Global Oral Polio Vaccines (OPV) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 104. Global Oral Polio Vaccines (OPV) Revenue Market Share Forecast by Application (2023-2028)
Table 105. Global Oral Polio Vaccines (OPV) Sales Forecast by Region (2023-2028) & (M Doses)
Table 106. Global Oral Polio Vaccines (OPV) Sales Market Share Forecast by Region (2023-2028)
Table 107. Global Oral Polio Vaccines (OPV) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 108. Global Oral Polio Vaccines (OPV) Revenue Market Share Forecast by Region (2023-2028)
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Polio Vaccines (OPV)
Figure 2. Global Oral Polio Vaccines (OPV) Market Share by Type in 2021 & 2028
Figure 3. Trivalent OPV Product Picture
Figure 4. Bivalent OPV Product Picture
Figure 5. Global Oral Polio Vaccines (OPV) Market Share by Application in 2021 & 2028
Figure 6. Public
Figure 7. Private
Figure 8. Global Oral Polio Vaccines (OPV) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Oral Polio Vaccines (OPV) Market Size (2017-2028) & (US$ Million)
Figure 10. Global Oral Polio Vaccines (OPV) Sales (2017-2028) & (M Doses)
Figure 11. Oral Polio Vaccines (OPV) Sales Share by Manufacturers in 2021
Figure 12. Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Oral Polio Vaccines (OPV) Players: Market Share by Revenue in 2021
Figure 14. Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2022)
Figure 16. Global Oral Polio Vaccines (OPV) Sales Market Share by Region in 2021
Figure 17. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2017-2022)
Figure 18. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region in 2021
Figure 19. U.S. Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Taiwan Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Philippines Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Vietnam Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. U.A.E Oral Polio Vaccines (OPV) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Oral Polio Vaccines (OPV) by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Oral Polio Vaccines (OPV)
Figure 45. Manufacturing Process Analysis of Oral Polio Vaccines (OPV)
Figure 46. Oral Polio Vaccines (OPV) Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock